Genmab A/S (GMAB)
USD 20.14
(0.55%)
USD 20.14
(0.55%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.35 Billion DKK | -20.18% |
| 2022 | 5.45 Billion DKK | 84.38% |
| 2021 | 2.95 Billion DKK | -37.85% |
| 2020 | 4.75 Billion DKK | 119.67% |
| 2019 | 2.16 Billion DKK | 47.13% |
| 2018 | 1.47 Billion DKK | 33.4% |
| 2017 | 1.1 Billion DKK | -7.04% |
| 2016 | 1.18 Billion DKK | 55.48% |
| 2015 | 763.51 Million DKK | 153.41% |
| 2014 | 301.29 Million DKK | 168.15% |
| 2013 | 112.36 Million DKK | 123.07% |
| 2012 | -487.11 Million DKK | 18.32% |
| 2011 | -596.36 Million DKK | -85.52% |
| 2010 | -321.45 Million DKK | 68.2% |
| 2009 | -1.01 Billion DKK | -4.73% |
| 2008 | -965.08 Million DKK | -151.74% |
| 2007 | -383.36 Million DKK | 12.52% |
| 2006 | -438.23 Million DKK | -11.34% |
| 2005 | -393.59 Million DKK | 5.21% |
| 2004 | -415.21 Million DKK | -26.93% |
| 2003 | -327.11 Million DKK | 31.76% |
| 2002 | -479.32 Million DKK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.32 Billion DKK | 107.03% |
| 2024 Q2 | 1.4 Billion DKK | 6.26% |
| 2023 Q4 | 640 Million DKK | -69.94% |
| 2023 Q1 | 210 Million DKK | -64.04% |
| 2023 FY | 4.35 Billion DKK | -20.18% |
| 2023 Q2 | 1.35 Billion DKK | 546.19% |
| 2023 Q3 | 2.12 Billion DKK | 56.89% |
| 2022 FY | 5.45 Billion DKK | 84.38% |
| 2022 Q4 | 584 Million DKK | -77.38% |
| 2022 Q1 | 465 Million DKK | -35.06% |
| 2022 Q2 | 1.89 Billion DKK | 306.67% |
| 2022 Q3 | 2.58 Billion DKK | 36.54% |
| 2021 FY | 2.95 Billion DKK | -37.85% |
| 2021 Q1 | 1.09 Billion DKK | 88.64% |
| 2021 Q3 | 890 Million DKK | 190.85% |
| 2021 Q4 | 716 Million DKK | -19.55% |
| 2021 Q2 | 306 Million DKK | -72.08% |
| 2020 Q3 | 530 Million DKK | -84.31% |
| 2020 FY | 4.75 Billion DKK | 119.67% |
| 2020 Q1 | 269 Million DKK | -81.72% |
| 2020 Q2 | 3.37 Billion DKK | 1155.76% |
| 2020 Q4 | 581 Million DKK | 9.62% |
| 2019 Q2 | 85 Million DKK | 18.06% |
| 2019 FY | 2.16 Billion DKK | 47.13% |
| 2019 Q4 | 1.47 Billion DKK | 174.09% |
| 2019 Q3 | 537 Million DKK | 531.76% |
| 2019 Q1 | 72 Million DKK | -91.37% |
| 2018 Q3 | 179.17 Million DKK | -31.23% |
| 2018 Q4 | 833.86 Million DKK | 365.39% |
| 2018 Q1 | 198.57 Million DKK | -74.73% |
| 2018 FY | 1.47 Billion DKK | 33.4% |
| 2018 Q2 | 260.52 Million DKK | 31.2% |
| 2017 FY | 1.1 Billion DKK | -7.04% |
| 2017 Q4 | 785.86 Million DKK | 13933.27% |
| 2017 Q3 | -5.68 Million DKK | -101.85% |
| 2017 Q2 | 307.26 Million DKK | 1808.6% |
| 2017 Q1 | 16.09 Million DKK | -98.09% |
| 2016 Q1 | -11.52 Million DKK | -102.96% |
| 2016 FY | 1.18 Billion DKK | 55.48% |
| 2016 Q3 | 188.95 Million DKK | 12.32% |
| 2016 Q2 | 168.23 Million DKK | 1559.7% |
| 2016 Q4 | 841.41 Million DKK | 345.29% |
| 2015 FY | 763.51 Million DKK | 153.41% |
| 2015 Q1 | 217.29 Million DKK | 214.81% |
| 2015 Q4 | 389.46 Million DKK | 177.66% |
| 2015 Q3 | 140.26 Million DKK | 750.67% |
| 2015 Q2 | 16.48 Million DKK | -92.41% |
| 2014 Q4 | 69.02 Million DKK | -56.84% |
| 2014 FY | 301.29 Million DKK | 168.15% |
| 2014 Q3 | 159.92 Million DKK | 711.56% |
| 2014 Q2 | -26.15 Million DKK | -126.55% |
| 2014 Q1 | 98.5 Million DKK | 64.53% |
| 2013 Q1 | 72.49 Million DKK | 120.15% |
| 2013 FY | 112.36 Million DKK | 123.07% |
| 2013 Q4 | 59.86 Million DKK | 1020.49% |
| 2013 Q3 | 5.34 Million DKK | 121.08% |
| 2013 Q2 | -25.34 Million DKK | -134.96% |
| 2012 Q4 | -359.79 Million DKK | -545.15% |
| 2012 Q3 | -55.77 Million DKK | -2587.71% |
| 2012 Q2 | -2.07 Million DKK | 97.01% |
| 2012 Q1 | -69.47 Million DKK | -58.6% |
| 2012 FY | -487.11 Million DKK | 18.32% |
| 2011 Q2 | -80.57 Million DKK | 27.56% |
| 2011 Q1 | -111.22 Million DKK | -32.55% |
| 2011 Q3 | -360.77 Million DKK | -347.77% |
| 2011 Q4 | -43.8 Million DKK | 87.86% |
| 2011 FY | -596.36 Million DKK | -85.52% |
| 2010 Q3 | -18.44 Million DKK | 79.2% |
| 2010 Q1 | -130.4 Million DKK | 78.54% |
| 2010 Q4 | -83.9 Million DKK | -354.85% |
| 2010 Q2 | -88.69 Million DKK | 31.99% |
| 2010 FY | -321.45 Million DKK | 68.2% |
| 2009 Q4 | -607.6 Million DKK | -578.54% |
| 2009 FY | -1.01 Billion DKK | -4.73% |
| 2009 Q2 | -114.44 Million DKK | 42.53% |
| 2009 Q1 | -199.15 Million DKK | 0.0% |
| 2009 Q3 | -89.54 Million DKK | 21.76% |
| 2008 FY | -965.08 Million DKK | -151.74% |
| 2007 FY | -383.36 Million DKK | 12.52% |
| 2006 FY | -438.23 Million DKK | -11.34% |
| 2005 FY | -393.59 Million DKK | 5.21% |
| 2004 FY | -415.21 Million DKK | -26.93% |
| 2003 FY | -327.11 Million DKK | 31.76% |
| 2002 FY | -479.32 Million DKK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | 29953.679% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 2032.075% |
| IO Biotech, Inc. | -86.08 Million USD | 5155.586% |
| VYNE Therapeutics Inc. | -28.45 Million USD | 15395.937% |
| Organovo Holdings, Inc. | -14.67 Million USD | 29763.963% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 108901.36% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 65397.314% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | 3830.563% |
| Aadi Bioscience, Inc. | -65.76 Million USD | 6717.502% |
| Savara Inc. | -54.69 Million USD | 8056.415% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | 5862.636% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 1872.023% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | 9857.122% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | 4527.356% |
| Soligenix, Inc. | -6.14 Million USD | 70971.053% |
| Aptose Biosciences Inc. | -51.2 Million USD | 8598.838% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | 5346.281% |
| Century Therapeutics, Inc. | -136.67 Million USD | 3284.243% |
| Eterna Therapeutics Inc. | -21.66 Million USD | 20184.918% |
| Precision BioSciences, Inc. | -61.31 Million USD | 7197.311% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 1919.109% |
| Kura Oncology, Inc. | -152.63 Million USD | 2951.321% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | 105358.626% |
| Dyadic International, Inc. | -6.79 Million USD | 64142.749% |
| TScan Therapeutics, Inc. | -89.21 Million USD | 4977.939% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | 3952.657% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | 764950.615% |
| Autolus Therapeutics plc | -208.38 Million USD | 2188.462% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | 465057.265% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | 6247.327% |
| GRI Bio, Inc. | -13.03 Million USD | 33481.913% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | 3607.302% |
| IGM Biosciences, Inc. | -246.41 Million USD | 1866.119% |
| Heron Therapeutics, Inc. | -110.55 Million USD | 4036.36% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 10414.315% |
| Entero Therapeutics, Inc. | -15.79 Million USD | 27653.053% |
| Opthea Limited | -220.24 Million USD | 2076.007% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | 4401.798% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 1676.092% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | 2797.476% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | -8244.518% |
| Surrozen, Inc. | -43.04 Million USD | 10211.054% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 85650.918% |
| Cingulate Inc. | -23.53 Million USD | 18591.65% |
| Ovid Therapeutics Inc. | -52.33 Million USD | 8415.03% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 859.72% |
| Acelyrin, Inc. | -381.64 Million USD | 1240.339% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | 2980.498% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | 8995.058% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | 14740.875% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | 2744.403% |
| ADMA Biologics, Inc. | -28.23 Million USD | 15511.311% |
| PureTech Health plc | -65.69 Million USD | 6724.351% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | 11123.582% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | 26499.757% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | 6033.44% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | 3061.31% |
| Synaptogenix, Inc. | -6.03 Million USD | 72170.831% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | 26950.938% |
| ChromaDex Corporation | -4.93 Million USD | 88232.847% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | 22970.496% |
| Monopar Therapeutics Inc. | -8.4 Million USD | 51895.983% |
| Exelixis, Inc. | 207.76 Million USD | -1994.674% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | 8481.319% |
| Better Therapeutics, Inc. | -39.76 Million USD | 11045.674% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | 3123.314% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 923.263% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 1787.927% |
| Seer, Inc. | -86.27 Million USD | 5144.218% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | 14253.306% |
| LAVA Therapeutics N.V. | -41.97 Million USD | 10468.323% |
| Gritstone bio, Inc. | -138.49 Million USD | 3242.465% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 6850.95% |
| Avid Bioservices, Inc. | -140.75 Million USD | 3191.941% |
| Insmed Incorporated | -749.56 Million USD | 680.602% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | 17326.774% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | 13896.602% |
| Fate Therapeutics, Inc. | -160.92 Million USD | 2804.315% |
| MediWound Ltd. | -6.71 Million USD | 64900.476% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | 2530.565% |
| Fortress Biotech, Inc. | -60.63 Million USD | 7277.136% |
| OmniAb, Inc. | -50.61 Million USD | 8697.562% |
| Seres Therapeutics, Inc. | -113.72 Million USD | 3926.809% |
| Zai Lab Limited | -334.62 Million USD | 1400.58% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 1443.268% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | 3302.52% |
| Veracyte, Inc. | -74.4 Million USD | 5949.148% |
| Abeona Therapeutics Inc. | -54.18 Million USD | 8131.298% |
| FibroGen, Inc. | -284.23 Million USD | 1631.144% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 5281.878% |
| ContextLogic Inc. | -317 Million USD | 1472.871% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | 41398.159% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 62254.647% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | 5434.641% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | -949.099% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | 65200.972% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | 19395.057% |
| ImmuCell Corporation | -5.77 Million USD | 75464.554% |
| Fortrea Holdings Inc. | -3.4 Million USD | 128100.0% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | 3536.404% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | 6850.95% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | 4521.596% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 817.395% |
| Theravance Biopharma, Inc. | -55.19 Million USD | 7985.058% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | 6476.09% |
| Vaxxinity, Inc. | -56.93 Thousand USD | 7644038.596% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 2021.082% |
| Gain Therapeutics, Inc. | -22.26 Million USD | 19644.161% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | 82421.746% |
| Marker Therapeutics, Inc. | -14.04 Million USD | 31084.142% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | 16255.617% |
| Senti Biosciences, Inc. | -92.91 Million USD | 4783.649% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | 41875.04% |
| Apollomics, Inc. | -172.6 Million USD | 2621.422% |
| 89bio, Inc. | -142.18 Million USD | 3160.715% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | 2220.083% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | 23565.856% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | 3826.091% |
| Ardelyx, Inc. | -66.06 Million USD | 6687.252% |
| Pluri Inc. | -20.88 Million USD | 20934.929% |
| Prothena Corporation plc | -147.02 Million USD | 3059.98% |
| Pulmatrix, Inc. | -14.12 Million USD | 30919.347% |
| Celularity Inc. | -196.29 Million USD | 2317.071% |
| MeiraGTx Holdings plc | -84.02 Million USD | 5279.288% |
| Omeros Corporation | -117.81 Million USD | 3793.99% |
| Ainos, Inc. | -13.77 Million USD | 31703.678% |
| Humacyte, Inc. | -110.77 Million USD | 4028.649% |
| Mesoblast Limited | -87.95 Million USD | 5047.929% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | 24299.288% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | 19078.675% |
| Blueprint Medicines Corporation | -506.98 Million USD | 958.41% |
| Cabaletta Bio, Inc. | -67.67 Million USD | 6530.735% |
| Summit Therapeutics Inc. | -614.92 Million USD | 807.725% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | 12484.747% |
| Scholar Rock Holding Corporation | -165.78 Million USD | 2725.023% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 1004.421% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | 4249.86% |
| Cytokinetics, Incorporated | -526.24 Million USD | 926.993% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | 12167.101% |
| Nutriband Inc. | -5.48 Million USD | 79439.123% |
| Protara Therapeutics, Inc. | -40.42 Million USD | 10866.947% |
| Roivant Sciences Ltd. | 4.34 Billion USD | -0.071% |
| Evogene Ltd. | -23.87 Million USD | 18325.219% |
| Applied Therapeutics, Inc. | -119.76 Million USD | 3733.844% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | 55572.067% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 776.615% |
| BioLineRx Ltd. | -60.61 Million USD | 7279.859% |
| Atai Life Sciences N.V. | -40.22 Million USD | 10919.411% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | 14921.879% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | 5678.057% |
| MediciNova, Inc. | -8.57 Million USD | 50872.815% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | 3630.261% |
| MiMedx Group, Inc. | 67.43 Million USD | -6353.239% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 794.538% |
| Cullinan Oncology, Inc. | -153.16 Million USD | 2941.436% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 2178.716% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 27365.338% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 14534.494% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | 4415.876% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 1944.56% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | -30800.312% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | 2355.366% |
| Allakos Inc. | -185.7 Million USD | 2443.552% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | 4571.156% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | -4000.245% |
| BioAtla, Inc. | -123.46 Million USD | 3624.971% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 1429.809% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | 11878.397% |
| Precigen, Inc. | -95.9 Million USD | 4637.871% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 90928.152% |
| XOMA Corporation | -40.83 Million USD | 10758.568% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | 4372.112% |
| Incyte Corporation | 597.59 Million USD | -628.248% |
| Cara Therapeutics, Inc. | -118.51 Million USD | 3772.171% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | 5063.56% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 17980.553% |
| CRISPR Therapeutics AG | -153.61 Million USD | 2933.149% |
| Akero Therapeutics, Inc. | -151.75 Million USD | 2967.705% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | 12492.152% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | 53881.911% |
| UroGen Pharma Ltd. | -102.24 Million USD | 4356.484% |
| Sutro Biopharma, Inc. | -106.79 Million USD | 4175.173% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | 56058.558% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | 20982.917% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | 4256.678% |
| Chimerix, Inc. | -82.09 Million USD | 5401.175% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | 7478.439% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | 115669.421% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | 3352.227% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | 30561.779% |
| Portage Biotech Inc. | -75.33 Million USD | 5876.557% |
| OncoCyte Corporation | -27.78 Million USD | 15765.383% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | 32535.949% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | 52175.568% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | 39231.342% |
| Purple Biotech Ltd. | -19.88 Million USD | 21991.348% |
| NextCure, Inc. | -62.72 Million USD | 7038.444% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | 24959.846% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | 55932.881% |
| Generation Bio Co. | -126.61 Million USD | 3537.273% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 1944.654% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | 7090.603% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | 121393.2% |
| NLS Pharmaceutics AG | -12.17 Million USD | 35854.105% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | 6153.02% |
| Novavax, Inc. | -545.06 Million USD | 898.441% |
| Virios Therapeutics, Inc. | -5.29 Million USD | 82274.994% |
| Curis, Inc. | -47.41 Million USD | 9278.917% |
| Daré Bioscience, Inc. | -30.16 Million USD | 14529.043% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | 78246.885% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | 28751.356% |
| Bicycle Therapeutics plc | -180.66 Million USD | 2508.892% |
| BeiGene, Ltd. | -881.7 Million USD | 593.587% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | 20537.682% |
| Alector, Inc. | -130.39 Million USD | 3437.654% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | 5612.001% |
| Erasca, Inc. | -125.04 Million USD | 3580.431% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | 8493.928% |
| Aura Biosciences, Inc. | -76.4 Million USD | 5795.739% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | 8623.64% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | 18067.879% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 87131.349% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | 17832.144% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | -2495.962% |
| Histogen Inc. | -10.62 Million USD | 41075.426% |
| Fortress Biotech, Inc. | -60.63 Million USD | 7277.136% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 2150.702% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 1954.819% |
| Galecto, Inc. | -38.34 Million USD | 11448.405% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | 56799.52% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | 2258.816% |
| Molecular Templates, Inc. | -8.12 Million USD | 53669.67% |
| PDS Biotechnology Corporation | -42.94 Million USD | 10234.553% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | -8732.782% |
| Amarin Corporation plc | -59.11 Million USD | 7462.295% |
| TG Therapeutics, Inc. | 12.67 Million USD | -34243.434% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | 25095.692% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | 3177.162% |
| Cogent Biosciences, Inc. | -192.41 Million USD | 2361.837% |
| Onconetix, Inc. | -37.4 Million USD | 11733.348% |
| MacroGenics, Inc. | -9.05 Million USD | 48145.926% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | 20410.823% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | 43681.013% |
| Adagene Inc. | -18.94 Million USD | 23070.099% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 1903.108% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 2080.793% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | -3188.748% |
| SciSparc Ltd. | -5.12 Million USD | 85066.81% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 3619106.436% |
| Minerva Neurosciences, Inc. | -30 Million USD | 14604.079% |
| Astria Therapeutics, Inc. | -72.89 Million USD | 6070.559% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | 5378.863% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 1760.182% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 1372.615% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 1088.547% |
| Psyence Biomedical Ltd. | -51.15 Million USD | 8606.804% |
| Artelo Biosciences, Inc. | -9.87 Million USD | 44175.349% |
| 2seventy bio, Inc. | -217.57 Million USD | 2100.276% |
| Clene Inc. | -49.5 Million USD | 8891.209% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | 8903.657% |
| GeoVax Labs, Inc. | -25.96 Million USD | 16859.887% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | 23208.749% |
| Arbutus Biopharma Corporation | -72.84 Million USD | 6074.001% |
| Scopus BioPharma Inc. | -11.6 Million USD | 37585.485% |
| Absci Corporation | -110.56 Million USD | 4036.111% |
| XBiotech Inc. | -24.55 Million USD | 17822.034% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | 2806.384% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | 7043.204% |
| Entera Bio Ltd. | -8.88 Million USD | 49059.388% |
| Trevena, Inc. | -40.28 Million USD | 10901.956% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | 3921.869% |
| Caribou Biosciences, Inc. | -102.07 Million USD | 4363.741% |
| INmune Bio, Inc. | -30 Million USD | 14602.799% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | 13473.112% |
| Tyra Biosciences, Inc. | -69.13 Million USD | 6395.021% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | 63062.963% |
| Unity Biotechnology, Inc. | -39.86 Million USD | 11018.214% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | 56541.247% |
| Jaguar Health, Inc. | -41.3 Million USD | 10637.53% |
| Clearside Biomedical, Inc. | -32.48 Million USD | 13496.952% |
| NexImmune, Inc. | -32.34 Million USD | 13555.192% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | 7413.917% |
| Clearmind Medicine Inc. | -11.95 Million USD | 36503.084% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | 20564.075% |
| Kronos Bio, Inc. | -112.67 Million USD | 3962.505% |
| Innoviva, Inc. | 179.72 Million USD | -2321.518% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 1929.402% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | -10.077% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | 6389.29% |
| Verastem, Inc. | -87.36 Million USD | 5081.286% |
| ProKidney Corp. | -35.46 Million USD | 12370.215% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 171593370.326% |
| Imunon, Inc. | -19.51 Million USD | 22400.821% |
| Viking Therapeutics, Inc. | -85.89 Million USD | 5166.651% |
| Statera Biopharma, Inc. | -174.4 Million USD | 2595.296% |
| ImmunityBio, Inc. | -583.19 Million USD | 846.233% |
| Korro Bio, Inc. | -81.17 Million USD | 5461.455% |
| Travere Therapeutics, Inc. | -111.39 Million USD | 4006.678% |
| Kineta, Inc. | -14.09 Million USD | 30967.437% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | -5994.385% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | 19626.604% |
| GT Biopharma, Inc. | -7.59 Million USD | 57385.771% |
| Keros Therapeutics, Inc. | -152.99 Million USD | 2944.593% |
| Celularity Inc. | -196.29 Million USD | 2317.071% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 2128.63% |
| CalciMedica, Inc. | -34.35 Million USD | 12766.997% |
| Cibus, Inc. | -267.62 Million USD | 1726.144% |
| C4 Therapeutics, Inc. | -132.49 Million USD | 3384.702% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | 3177.685% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | 10892.045% |
| Kodiak Sciences Inc. | -260.49 Million USD | 1770.691% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 1636.425% |
| Annexon, Inc. | -134.23 Million USD | 3342.027% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | 3814.42% |
| Assembly Biosciences, Inc. | -61.22 Million USD | 7207.859% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | 12465.393% |
| Moderna, Inc. | -4.71 Billion USD | 192.321% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | 5366.342% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 1288.143% |
| Vor Biopharma Inc. | -117.86 Million USD | 3792.423% |
| Eyenovia, Inc. | -27.26 Million USD | 16064.142% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | 22554.982% |
| Puma Biotechnology, Inc. | 21.59 Million USD | -20056.547% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | 3315.32% |
| Wave Life Sciences Ltd. | -57.51 Million USD | 7666.985% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 813557.944% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | 7201.132% |
| Immunocore Holdings plc | -55.28 Million USD | 7971.652% |
| Tango Therapeutics, Inc. | -101.74 Million USD | 4377.402% |
| Galectin Therapeutics Inc. | -41.06 Million USD | 10697.575% |
| Alkermes plc | 355.75 Million USD | -1123.307% |
| Arcellx, Inc. | -70.69 Million USD | 6256.458% |
| Renovaro Biosciences Inc. | -80.65 Million USD | 5496.145% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 1589.437% |
| Sagimet Biosciences Inc. | -27.87 Million USD | 15711.996% |
| Regulus Therapeutics Inc. | -30.03 Million USD | 14588.797% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 52052.802% |
| Moolec Science SA | -51.78 Million USD | 8503.348% |
| Biomea Fusion, Inc. | -117.25 Million USD | 3811.569% |
| RenovoRx, Inc. | -10.23 Million USD | 42633.229% |
| Geron Corporation | -184.12 Million USD | 2463.586% |
| Mereo BioPharma Group plc | -29.46 Million USD | 14869.565% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | 6596.007% |
| Royalty Pharma plc | 1.13 Billion USD | -283.492% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | 3301.036% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | 49043.954% |
| Calithera Biosciences, Inc. | -18.86 Million USD | 23167.953% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | 20586.526% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | 2635.096% |
| Humacyte, Inc. | -110.77 Million USD | 4028.649% |
| Structure Therapeutics Inc. | -89.62 Million USD | 4956.059% |
| NLS Pharmaceutics AG | -12.17 Million USD | 35854.105% |
| Genelux Corporation | -28.29 Million USD | 15479.722% |
| ESSA Pharma Inc. | -26.58 Million USD | 16471.77% |
| aTyr Pharma, Inc. | -50.38 Million USD | 8736.806% |
| Notable Labs, Ltd. | -11.26 Million USD | 38736.364% |
| Alzamend Neuro, Inc. | -9.94 Million USD | 43848.604% |
| Mustang Bio, Inc. | -51.6 Million USD | 8533.782% |
| Immunovant, Inc. | -259.33 Million USD | 1778.132% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 6464266.357% |
| Vericel Corporation | -3.18 Million USD | 136869.327% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | -1445.487% |
| Akari Therapeutics, Plc | -10 Million USD | 43585.212% |
| Acasti Pharma Inc. | -12.85 Million USD | 33959.799% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | 19478.517% |
| Vaxcyte, Inc. | -402.26 Million USD | 1181.871% |
| Orgenesis Inc. | -55.36 Million USD | 7961.13% |
| Spruce Biosciences, Inc. | -47.91 Million USD | 9181.993% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | 34999.759% |
| GH Research PLC | -35.58 Million USD | 12329.185% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | 14857.045% |
| PepGen Inc. | -78.62 Million USD | 5635.065% |
| Moleculin Biotech, Inc. | -29.76 Million USD | 14719.235% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | 4505.226% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 90928.152% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | 85650.918% |
| Silo Pharma, Inc. | -3.7 Million USD | 117699.913% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | 33392.88% |
| Belite Bio, Inc | -31.63 Million USD | 13858.22% |
| Pharming Group N.V. | -10.54 Million USD | 41359.006% |
| XOMA Corporation | -40.83 Million USD | 10758.568% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | 5723.611% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | 17980.553% |
| Bionomics Limited | -15.49 Billion USD | 128.092% |
| Xencor, Inc. | -126.08 Million USD | 3551.585% |
| Replimune Group, Inc. | -215.79 Million USD | 2116.738% |
| Pyxis Oncology, Inc. | -73.79 Million USD | 5997.818% |
| Cassava Sciences, Inc. | -97.21 Million USD | 4576.583% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | -173355.56% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 59620.854% |
| Turnstone Biologics Corp. | -55.2 Million USD | 7984.058% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 21547.933% |
| GeoVax Labs, Inc. | -25.96 Million USD | 16859.887% |
| MEI Pharma, Inc. | 17.77 Million USD | -24379.694% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | 4602.612% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | 52052.802% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | 27168.043% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | 15071.79% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | 62103.134% |
| scPharmaceuticals Inc. | -54.81 Million USD | 8040.157% |
| HilleVax, Inc. | -123.56 Million USD | 3622.004% |
| Vera Therapeutics, Inc. | -95.99 Million USD | 4633.806% |
| Tharimmune, Inc. | -9.31 Million USD | 46799.819% |
| Genprex, Inc. | -30.86 Million USD | 14202.187% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 16690.424% |
| Immunic, Inc. | -93.61 Million USD | 4748.977% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | 14561.354% |
| Aptorum Group Limited | -2.82 Million USD | 154172.35% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | 11262.409% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | 16690.424% |
| OKYO Pharma Limited | -16.82 Thousand USD | 25865663.259% |
| Carmell Therapeutics Corporation | -15.44 Million USD | 28277.245% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | 14696.68% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | -769525.267% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | 2971.015% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | 34697601.094% |
| bluebird bio, Inc. | -211.91 Million USD | 2153.673% |
| DBV Technologies S.A. | -72.72 Million USD | 6084.105% |
| Compugen Ltd. | -18.75 Million USD | 23305.716% |
| Protagenic Therapeutics, Inc. | -5 Million USD | 87131.349% |
| Peak Bio, Inc. | -1259.26 USD | 345599896.706% |
| Vincerx Pharma, Inc. | -40.15 Million USD | 10937.463% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | 76531.331% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | 12862.089% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | 8959.935% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | 9550.802% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | 7306.73% |
| Benitec Biopharma Inc. | -21.75 Million USD | 20108.275% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 1384.572% |
| Adicet Bio, Inc. | -142.65 Million USD | 3150.653% |
| Prime Medicine, Inc. | -198.13 Million USD | 2296.504% |
| Aditxt, Inc. | -32.38 Million USD | 13540.047% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 1264.789% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 59620.854% |
| Quantum-Si incorporated | -95.96 Million USD | 4635.223% |
| GlycoMimetics, Inc. | -36.89 Million USD | 11894.223% |
| PolyPid Ltd. | -23.86 Million USD | 18335.91% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | 27763.361% |
| Invivyd, Inc. | -198.64 Million USD | 2290.865% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | 50200.31% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | 17444.865% |
| CorMedix Inc. | -46.33 Million USD | 9491.611% |
| Instil Bio, Inc. | -156.08 Million USD | 2888.189% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 1426.562% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | -19054.93% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | 5921.762% |
| Spero Therapeutics, Inc. | 22.8 Million USD | -18982.698% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 15026.09% |
| AbCellera Biologics Inc. | -146.39 Million USD | 3072.718% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | 5490.408% |
| Surrozen, Inc. | -43.04 Million USD | 10211.054% |
| Janux Therapeutics, Inc. | -58.29 Million USD | 7565.733% |
| Verona Pharma plc | -54.36 Million USD | 8104.561% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | 4924.299% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 807.572% |
| Evaxion Biotech A/S | -22.12 Million USD | 19770.056% |
| Verve Therapeutics, Inc. | -200.06 Million USD | 2275.26% |
| Shattuck Labs, Inc. | -87.29 Million USD | 5085.223% |
| AlloVir, Inc. | -190.41 Million USD | 2385.498% |
| BioVie Inc. | -32.12 Million USD | 13648.966% |
| Codexis, Inc. | -76.24 Million USD | 5808.29% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | 11755.062% |
| Lexaria Bioscience Corp. | -6.66 Million USD | 65397.314% |
| Agenus Inc. | -245.76 Million USD | 1870.826% |
| Virax Biolabs Group Limited | -6.73 Million USD | 64731.708% |
| Lantern Pharma Inc. | -15.96 Million USD | 27365.55% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 1930.617% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | 12252.691% |
| Immix Biopharma, Inc. | -15.42 Million USD | 28312.022% |
| Celcuity Inc. | -63.77 Million USD | 6923.55% |
| Cardiff Oncology, Inc. | -41.44 Million USD | 10601.677% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | 8409.943% |
| IN8bio, Inc. | -30 Million USD | 14603.283% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | 42038.903% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | 15073.336% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | 2557.105% |
| Liquidia Corporation | -78.5 Million USD | 5643.808% |
| Quantum-Si incorporated | -95.96 Million USD | 4635.223% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | 27365.338% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | 2486.056% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | 16077.678% |
| United Therapeutics Corporation | 984.8 Million USD | -341.917% |
| Solid Biosciences Inc. | -96.01 Million USD | 4632.625% |
| Immuneering Corporation | -53.47 Million USD | 8238.897% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | 15026.09% |
| uniQure N.V. | -308.47 Million USD | 1510.798% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | 5796.037% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | 25168200.589% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | 3625.885% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | 8096.766% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | 6410.905% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | 101273.609% |
| Cue Biopharma, Inc. | -50.73 Million USD | 8678.243% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | 19650.764% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | 8105.15% |
| Zura Bio Limited | -60.36 Million USD | 7310.073% |
| Forte Biosciences, Inc. | -31.47 Million USD | 13926.407% |
| Elevation Oncology, Inc. | -45.7 Million USD | 9622.142% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | 813557.944% |
| Immunome, Inc. | -106.8 Million USD | 4174.677% |
| Compass Therapeutics, Inc. | -42.49 Million USD | 10341.446% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | 4455.615% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | 3320.904% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | 3591.348% |
| Altimmune, Inc. | -88.44 Million USD | 5020.461% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | 7391.614% |
| Rallybio Corporation | -74.56 Million USD | 5936.597% |
| Plus Therapeutics, Inc. | -13.31 Million USD | 32782.487% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | 10091.964% |
| Moolec Science SA | -51.78 Million USD | 8503.348% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | 53162.151% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | 244319.978% |
| Tourmaline Bio, Inc. | -42.12 Million USD | 10431.403% |
| NeurAxis, Inc. | -14.62 Million USD | 29853.841% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | 3756.252% |
| Lumos Pharma, Inc. | -34.03 Million USD | 12887.213% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | 4455.615% |
| 180 Life Sciences Corp. | -19.93 Million USD | 21930.828% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | 5346.281% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | -144542.863% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | 171593370.326% |
| Nutriband Inc. | -5.48 Million USD | 79439.123% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | 9053.443% |
| argenx SE | -295.05 Million USD | 1574.989% |
| Neurogene Inc. | -36.31 Million USD | 12083.369% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | 2763.158% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | 51293.977% |
| CervoMed Inc. | -2.17 Million USD | 200480.041% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | 4534.165% |
| Sesen Bio, Inc. | -19.88 Million USD | 21986.944% |
| AnaptysBio, Inc. | -163.61 Million USD | 2759.838% |
| Design Therapeutics, Inc. | -66.86 Million USD | 6608.929% |
| Leap Therapeutics, Inc. | -81.41 Million USD | 5445.518% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | 11588.306% |
| Achilles Therapeutics plc | -69.66 Million USD | 6347.039% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | 43159.266% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | 4421.877% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | 5745.276% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | 12911.304% |
| MoonLake Immunotherapeutics | -36 Million USD | 12186.451% |
| Palisade Bio, Inc. | -12.3 Million USD | 35482.114% |
| Beam Therapeutics Inc. | -132.52 Million USD | 3383.859% |
| AEON Biopharma, Inc. | -52.55 Million USD | 8380.691% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | 6179.571% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | 34877.339% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 1080.099% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | 4000.83% |
| Athira Pharma, Inc. | -117.67 Million USD | 3798.416% |
| Vaccinex, Inc. | -20.25 Million USD | 21590.297% |
| HCW Biologics Inc. | -24.99 Million USD | 17511.986% |
| XOMA Corporation | -40.83 Million USD | 10758.568% |
| Nektar Therapeutics | -276.05 Million USD | 1676.492% |
| Arvinas, Inc. | -367.3 Million USD | 1284.863% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | 6464266.357% |
| Merus N.V. | -154.93 Million USD | 2908.847% |
| Omega Therapeutics, Inc. | -97.42 Million USD | 4566.888% |
| Quince Therapeutics, Inc. | -31.38 Million USD | 13966.497% |
| Rezolute, Inc. | -68.45 Million USD | 6457.09% |
| Clene Inc. | -49.5 Million USD | 8891.209% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 28316.735% |
| BeyondSpring Inc. | -21.02 Million USD | 20798.183% |
| Synlogic, Inc. | -57.28 Million USD | 7697.5% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | 36668.356% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | 40299.52% |
| Peak Bio, Inc. | -1259.26 USD | 345599896.706% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | 11746.328% |
| Krystal Biotech, Inc. | 10.93 Million USD | -39709.733% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | 3141.251% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 1438.649% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | 94320.242% |
| MannKind Corporation | -11.93 Million USD | 36555.018% |
| Ikena Oncology, Inc. | -68.16 Million USD | 6484.415% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | 20809.017% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | 4782.944% |
| Gossamer Bio, Inc. | -179.81 Million USD | 2520.238% |
| CohBar, Inc. | -11.96 Million USD | 36481.514% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | 16976.066% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | 14534.494% |
| Legend Biotech Corporation | -518.25 Million USD | 939.743% |
| Mural Oncology plc | -207.44 Million USD | 2197.885% |
| Biora Therapeutics, Inc. | -124.11 Million USD | 3606.425% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | 23894.781% |
| Disc Medicine, Inc. | -76.42 Million USD | 5794.174% |
| Champions Oncology, Inc. | -7.27 Million USD | 59913.084% |
| REGENXBIO Inc. | -263.49 Million USD | 1751.651% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | 41106.027% |
| Anavex Life Sciences Corp. | -47.5 Million USD | 9261.141% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | 11557.608% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | 4444.918% |
| Vaxart, Inc. | -82.46 Million USD | 5377.39% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | -1303819.248% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | 11692.192% |
| Cellectis S.A. | -101.05 Million USD | 4406.395% |
| Longeveron Inc. | -21.41 Million USD | 20424.102% |
| Repare Therapeutics Inc. | -93.79 Million USD | 4739.857% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 911.975% |
| Inozyme Pharma, Inc. | -71.16 Million USD | 6215.022% |
| Revolution Medicines, Inc. | -436.36 Million USD | 1097.326% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | 66330.406% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | 14218.868% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | 6376.953% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | 6823.104% |
| Anixa Biosciences, Inc. | -9.81 Million USD | 44458.373% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | -20.234% |
| Denali Therapeutics Inc. | -145.22 Million USD | 3096.75% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | 3619106.436% |
| Veru Inc. | -93.15 Million USD | 4771.899% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | 16201.225% |
| Cingulate Inc. | -23.53 Million USD | 18591.65% |
| Passage Bio, Inc. | -102.06 Million USD | 4364.075% |
| Context Therapeutics Inc. | -23.96 Million USD | 18260.414% |
| Exicure, Inc. | -16.91 Million USD | 25830.164% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | 2403.657% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | 11624.203% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 1097.326% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | 66978.485% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | 2456.534% |
| Nuvalent, Inc. | -126.21 Million USD | 3547.975% |
| ABVC BioPharma, Inc. | -10.51 Million USD | 41485.911% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | 5109.266% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | 14348.298% |
| OmniAb, Inc. | -50.61 Million USD | 8697.562% |
| Anew Medical, Inc. | 1.34 Million USD | -323198.356% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | 27223.715% |
| Lipocine Inc. | -16.35 Million USD | 26714.348% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | 6654.809% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | 6934.707% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | 10414.315% |
| G1 Therapeutics, Inc. | -47.96 Million USD | 9172.904% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | 22045.439% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 903.71% |
| Ocugen, Inc. | -63.07 Million USD | 6999.394% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | 4646.024% |
| Q32 Bio Inc. | -112.96 Million USD | 3952.657% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | 25414.1% |
| Alumis Inc. Common Stock | -154.99 Million USD | 2907.869% |
| Equillium, Inc. | -13.33 Million USD | 32735.921% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | 7309.356% |
| Coya Therapeutics, Inc. | -7.98 Million USD | 54582.841% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | 23186.032% |
| Galera Therapeutics, Inc. | -59.08 Million USD | 7466.034% |
| Evelo Biosciences, Inc. | -114.52 Million USD | 3899.977% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | 23780.547% |
| Dominari Holdings Inc. | -22.88 Million USD | 19119.316% |
| Edesa Biotech, Inc. | -8.37 Million USD | 52067.809% |
| vTv Therapeutics Inc. | -20.25 Million USD | 21591.358% |
| Bio-Techne Corporation | 168.1 Million USD | -2488.858% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 1336.055% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | -3277.492% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | 3672.132% |
| Candel Therapeutics, Inc. | -37.93 Million USD | 11571.046% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | 3963.568% |
| Nkarta, Inc. | -117.5 Million USD | 3803.798% |
| BioCardia, Inc. | -11.57 Million USD | 37711.27% |
| Iterum Therapeutics plc | -38.37 Million USD | 11441.899% |